Titan Pharmaceuticals
TTNP
#11021
Rank
C$8.6 M
Marketcap
C$6.47
Share price
-3.76%
Change (1 day)
17.85%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -C$3.92 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$6.61 Million, an increase over its 2023 earnings that were of -C$7.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$3.92 Million-40.73%
2024 -C$6.61 Million-15.5%
2023 -C$7.82 Million-45.43%
2022 -C$14.32 Million16.29%
2021 -C$12.32 Million-907.36%
2020 C$1.52 M-106.6%
2019 -C$23.1 Million82.4%
2018 -C$12.66 Million-36.93%
2017 -C$20.08 Million-378.62%
2016 C$7.2 M-145.53%
2015 -C$15.83 Million369.37%
2014 -C$3.38 Million-125.9%
2013 C$13.01 M-177.74%
2012 -C$16.75 Million13.59%
2011 -C$14.75 Million74.37%
2010 -C$8.46 Million3.61%
2009 -C$8.16 Million
2007 -C$25.87 Million12.08%
2006 -C$23.08 Million-28.65%
2005 -C$32.35 Million-10.03%
2004 -C$35.95 Million-6.08%
2003 -C$38.28 Million-14.76%
2002 -C$44.91 Million32.52%
2001 -C$33.89 Million27.55%
2000 -C$26.57 Million62.5%
1999 -C$16.35 Million4.04%
1998 -C$15.72 Million49.33%
1997 -C$10.53 Million-27.88%
1996 -C$14.6 Million13.04%
1995 -C$12.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.44 B-926,267.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.14 B-562,809.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-C$0.23 Billion 5,617.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$0.10 B-2,882.64%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$16.44 Million 317.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.44 Billion 10,918.25%๐Ÿ‡บ๐Ÿ‡ธ USA